Alignment Healthcare (NASDAQ:ALHC) Issues Quarterly Earnings Results

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) issued its earnings results on Thursday. The company reported ($0.16) earnings per share for the quarter, topping analysts' consensus estimates of ($0.18) by $0.02, Zacks reports. The business had revenue of $701.24 million for the quarter, compared to the consensus estimate of $677.42 million. Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. Alignment Healthcare updated its Q1 2025 guidance to EPS and its FY 2025 guidance to EPS.

Alignment Healthcare Stock Performance

NASDAQ:ALHC traded down $0.17 during mid-day trading on Monday, hitting $15.52. 4,273,010 shares of the stock were exchanged, compared to its average volume of 2,000,523. The firm's 50-day simple moving average is $13.60 and its 200 day simple moving average is $12.04. The stock has a market capitalization of $2.98 billion, a price-to-earnings ratio of -20.16 and a beta of 1.50. Alignment Healthcare has a fifty-two week low of $4.46 and a fifty-two week high of $16.25. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60.

Insider Buying and Selling at Alignment Healthcare

In related news, insider Hakan Kardes sold 10,500 shares of the stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $14.99, for a total transaction of $157,395.00. Following the sale, the insider now owns 309,944 shares of the company's stock, valued at $4,646,060.56. This represents a 3.28 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO John E. Kao sold 90,000 shares of Alignment Healthcare stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $11.65, for a total value of $1,048,500.00. Following the completion of the transaction, the chief executive officer now directly owns 2,363,100 shares of the company's stock, valued at $27,530,115. This represents a 3.67 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 441,002 shares of company stock valued at $5,772,726 in the last ninety days. 6.60% of the stock is currently owned by corporate insiders.

Remove Ads

Analyst Ratings Changes

Several research analysts have recently weighed in on ALHC shares. Stephens restated an "overweight" rating and set a $17.00 price objective on shares of Alignment Healthcare in a research note on Monday, February 24th. Stifel Nicolaus boosted their price target on Alignment Healthcare from $16.00 to $18.00 and gave the stock a "buy" rating in a research report on Friday. Barclays upped their price objective on Alignment Healthcare from $8.00 to $9.00 and gave the company an "underweight" rating in a research note on Friday. Finally, William Blair reiterated an "outperform" rating on shares of Alignment Healthcare in a research note on Friday. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $12.25.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.